Iron Horse Diagnostics, Inc.
Iron Horse has diagnostics for ALS and TBI/Concussion. The ALS diagnostic is undergoing a final clinical validation with grant funding from NIH & Biogen Idec.
Iron Horse has two diagnostic products in development. The first for ALS/Lou Gehrig’s Disease, will be market ready as a laboratory developed test (LDT) after a final validation study to be completed in 2016 conducted with non-dilutive grant funding from NIH and big Pharma partner Biogen Idec. Our second diagnostic product is for traumatic brain injury and concussion. A $17 BN market with an anticipated market release in 2018.